| Introduction
These dinucleotides have been found in human plate-, \ Diadenosine tetraphosphate hydrolase is a nucleotide lets in abundant amounts (2, 3) . After activation of < pyrophosphatase (EC 3.6.1.9) which occurs both in the platelets both dinucleotides are released into the l human plasma and serum. There are no differences surrounding medium (2, 3) . Recently a physiological l of activity between the two body fluids. The enzyme role of A
Ps
A and A P4 A in the haemostatic process i has been highly purißed in our laboratory (1) . It is a has been claimed. Ap 3 A has been shown to be an ; |' glycoprotein complex with a relative molecular mass inducer of platelet aggregation, whereas Ap 4 A in-'i of about M T =200000. Fof füll enzyme activity hibits this process (4) . It is interesting that Ap 3 A itself ! the hydrolase needs divalent cations. The Substrate does not tri gg er aggregation. The final trigger is ADP, specificity is not confined to diadenosine tetraphoswhich is generated from Ap 3 A by the action of the : phate (Ap 4 A). The homologue dinucleotide diadeno, nucleotide pyrophosphatase. Variations of its activity sine triphosphate (Ap 3 A) is also cleaved yielding ADP ma V *>* of significance for processes such äs throm-| and AMP äs products. Several other nucleotides are bosis and haemostasis. attacked by the enzyme, but the preferred Substrates Data on the catalytic activity concentration of the of the pyrophosphatase are the dinucleotides Ap 3 A enzyme under normal äs well äs under various pathoand Ap 4 A (1).
logical conditions were hitherto lacking. The possible use of the enzyme äs a tool in clinical biochemistry needs to be evaluated. In this pilot study we have focussed on inpatients of a medical clinic.
Since we measured enzyme activity in the present study with a bioluminescence assay, using 
Materials and Methods

Sera
Fourty normal sera were obtained from healthy laboratory workers or from students. Their age ranged between 20 and 35 years (24 men, 16 women). Pathological sera were obtained from the University Hospital Erlangen-Nürnberg (medical clinic). Samples (n = 207) were collected within one month on four different days. The ratio between males and feinales was 1.5. The patients' age ranged from 19 to 88 years.
Further Information on the patients was available in 182 of the 207 cases. In addition to the diagnosis, we utilized several laboratory parameters, such äs serum protein, serum albumin, total bilirubin, amylase (serum), aspartate aminotransferase, alanine aminotransferase, -glutamyl transferase and lactate dehydrogenase. These values were taken from the medical records.
All the sera were stored frozen at -20 °C. Diadenosine tetraphosphate hydrolase activities of the sera were determined within four weeks after receipt of the samples. There was no evidence of a loss of enzyme activity during this time.
Determination of diadenosine tetraphosphate hydrolase activity in human serum
We have used a slightly modified bioluminescence method which has already been described in detail (1) . In principle, Ap 4 A is cleaved by the hydrolase, yielding AMP and ATP äs products. ATP is detected by the luciferin-luciferase reaction.
The reaction assay contained in a total volume of 0. The increase of luminescence was monitored with a photomultiplier (Lumacounter Model 2080; Lumac Systems AG, Switzerland) every 30 seconds (Integration mode). The increase of bioluminescence during the first niinute after addition of enzyme (serum) was taken äs initial velocity.
Since the luminescence of the AMR (per pmol of ATP) decreased with prolonged storage at room temperature, a calibration of the assay was necessary. This was performed by adding a Standard quantity of ATP (2 pmol) to the reaction mixtüre described above, but in the absence of Ap 4 A and serum. Activity determinations of four sera and one calibration experiment were run in parallel. The value of one calibration was taken äs reference value. Ratios of the reference value and the values obtained from the other calibration experiments were used to correct the serum enzyme activities.
Results
Diadenosine tetraphosphate hydrolase assay
The linear relationship between diadenosine tetraphosphate hydrolase activity and the amount of serum in the assay is deirionstrated in figure 1. Two sera with different levels of enzyme activity were used. With both samples the hydrolase activities were linear up to 9 of serum. For roütine measurements enzyme activity was determined with 2 and 5 of serüm, respectively, both sample volurnes therefore being within the linear ränge of the te$t. The linear relationship between the amount of enzyme preserit in the assay and the induced bioluminescence indicated that quench phenomena played no major role.
The imprecision of the test was evaluated äs follows. About 80 sera were pooled and stored in small portions at -20 P C. Each deterinination was performed with a freshly thawed sample. Diadenosine tetraphos- phate hydrolase activities were measured on seven days within a period of five months. Five independent determinations were run per day. The imprecision (expressed äs Variation coefficients) on the seven days were 7.9%, 7.5%, 7.4%, 6.8%, 7.5%, 11.6% and 9.6%, respectively. The corresponding mean values of the hydrolase activities were 117.4, 103.5, 110.9, 105.3, 83.8, 114.0 and 96.2 mU/1 of serum, respectively. The reproducibility from day to day (11%) was a little worse than the reproducibility on one day (see above).
There was no evidence of a loss of enzyme activity during a storage period of 5 months (at -20 °C).
A comparison of enzyme activities in serum and plasma revealed no differences. Also no differences were found in slightly haemolytic and non-haemolytic sera.
Diadenosine tetraphosphate hydrolase activities in normal and pathological sera
The activities of 40 healthy volunteers and of 207 inpatients from the local medical clinic were measured. The results are demonstrated äs a relative frequency histogram in figure 2 . The mean values of the activities of the normal serä and of the pathological sera were 90.5 ±21.0 (± SD) and 159.1 ± 45.2 (± SD) mU/1 serum, respectively. Plotting of the data on probability paper revealed a Gausn&n distribution for both groups. The differences between the mean activities were highly sigriificant (p < 0.001, test of Wilcoxon, Mann & Whitney).
Since both groups were heterogenous with respect to their age we wanted to rule out a possible inflüeüce of age on the enzyme activity (the age of the normal donors ranged between 20 and 35 years, the age of the patients between 19 and 88). Therefore the reference group was compared only with those patients under the age of 35. The results did not change essentially. On the contrary, the difference between both groups increased slightly (mean ± SD of the patients: 180.1 ± 37.7 mU/1 of serum, n = 38) ( fig. 3 ). We then divided the group of inpatients into three classes of different age. The subgroups were designated äs A « 45 years), B (46-60 years) and C (>60 years). The mean enzyme activities in A, B and C were 179.6 ± 39.1 (± SD, n = 58) 154.6 ± 47.1 (±SD, n = 68) and 145.5 ± 43.8 mU/1 of serum (±SD, n = 79), respectively. Thus a slight decrease of the hydrolase activity was observed with increasing age.
Furthermore there were no differences between males and females. The mean enzyme activities of the inpatients were 160.9 ± 48.2 (± SD, n = 124) and 156.1 ± 38.6 mU/1 of serum (± SD, n = 83), respectively. The healthy donors also showed no differences between the sexes.
When the diadenosine tetraphosphate hydrolase activities were compared with the diagnoses (fig. 4 ) increased äs well äs normal values were found with all disorders. Sera showing increased activities predominated in all groups. Patients with pancreatitis always had elevated levels of the hydrolase activity.
Diadenosine tetraphosphate hydrolase and other läboratory parameters
We compared the hydrolase activities in the serum with several other enzymes and with bilirubin (tab. 1). It is remarkable that 63.3% of the inpatients had Results from 163 of 207 sera measured for enzyme catalytic activity concentrations could be related to a clear diagnosis. The group "heart diseases" mainly consisted of myocardial infarctions, coronary heart diseases and cardiac insufflciencies. Benign disorders of the lungs were pneumonia, emphysema and bronchitis. Acute and chronic myeloid leukaemia, Hodgkm's disease and malignant lymphomas were subsumed under "neoplasms of the blood". The group "other dieseases" cbntained 44 cases with 26 different disofders, both of benign and malignant nature. The dashed lines indicate the mean ± 2 SD ränge of the catalytic concentrations from the normal donors. For reasons of clarity open and closed circles were used by turns.
increased levels of the diadenosine tetraphosphate hydrolase whereas the other values were elevated only in 26 -40% of the cases, with the exception ofglutamyl transferase, which also showed increased activities in about two thirds of the patients.
Comparison of the correlations between diadenosine tetraphosphate hydrolase and the seven other parameters (tab. 1), revealed small, but statistically significant correlations between the hydrolase and alkaline phosphatase, alänine aminotransferase, and -glutamyl transferase. The highest correlation was found with -glutamyl transferase. Of 117 patients with increased -glutamyl transferase 63.2% showed increased catalytic concentrations öf the hydrolase.
It is noteworthy, however, that 67.2% of the 61 cases' with normal -glutamyl transferase values also exhibited elevated activities of the diadenosine tetraphosphate hydrolase. Thus many patients with normal -glutamyl transferase, i. e. no sign of liver disease or accompanying liver reaction, had increased catalytic concentrations of the hydrolase. Arialysis of the diagnoses of this group revealed that 53% suffered from gastrointestinal disorders (benign and malignant states of the stomach, small intestine and the colon). In the group of patients with increased levels of both enzyme activities, diseases of the gastrointest inal tract were only present in 12% of the cases. This was also true for the group with the constellation "increased -glutamyl transferase and normal diadenosine tetraphosphate hydrolase".
Discussion
Diadenosine tetraphosphate hydrolase is an enzyme which occurs in human serum and plasma in equally high amounts. It has been highly purified and partially characterized in our laboratory (1) . The puirpose of this study was to obtain information on tihe hydrolase levels in normals; Furtherrnöre about 200 sera from inpatients of a medical clinic were measured in order to study the enzyme levels in various pathological conditions. Whether the diadenosine tetraphosphate hydrolase might be of value äs a diagiiostic tool in clinical biochemistfy was a further question.
This study clearly showed that inpatients had significantly increased levels of diadenosine tetraphosphate hydrolase activity äs compared to the reference group. When relating enzyme activities with the diagnoses of the patients, increased hydrolase levels were found in quite different disorders. Thus elevation of the enzyme was not a specific marker for any particular disorder. At present, this enzyme has no obvious relevance äs a diagnostic aid.
However, it should be stressed that about 64% of the patients showed increased values, whereas only 5% of the healthy donors had increased activity levels. Increased values of the diadenosine tetraphosphate hydrolase are not indicative of a specific disease, but elevated levels might be a general sign of illness. One should keep in mind that we have investigated a selected collective, namely typical patients of a medical clinic.
Nothing is known about the organ source of the elevated diadenosine tetraphosphate hydrolase levels.
A direct approach to the investigation of organ distribution by measuring the hydrolase activities in homogenates of various organs would not give unambiguous results, because of the complexity of the Ap4A degrading activities; i. e. several cytosolic and particulate activities seem to coexist in a wide variety of tissues (9, 10) . However, in this regard the present work may give some hints.
Since various diseases exhibited increased levels of the hydrolase one may assume that this enzyme is present in many organs and tissues. However, this assumption is not essential to the Interpretation. For example, -glutamyl tränsferase was also increased in about twp thirds of the cases, and it is known that this enzyme is almost only increased in diseases and reactions of the liver (and biliary tract) (5). This is explained by the fact that many diseases are accompaiiied by reactionjs of the liver.
This explanation cpuld also hold true for the diadenoŝ ine tetraphosphate hydrolase. The elevations of enzyme activity wöuld then be attributable to the liver. Several of pur results support the hypothesis that the liver is a source of the hydrolase. When comparing the diadenosine tetraphpsphate hydrolase with other laboratory paranpieters the close correlation withglutamyl transferase was remarkable. 63.5% of the sera showing increased catalytic concentration ofglutamyl transferase also had elevated activities of the Ap4A hydrolase.
Besides the liver, other organs may act äs a source of the serum enzyme activity. Ofthose patients showing a normal -glutamyl transferase activity, i. e. with no indication for liver cell damage (transaminases were also in the reference ränge), about 67% had increased levels of the diadenosine tetraphosphate hydrolase. This points to another organ or tissue äs a source for increased hydrolase activities. It is remarkable that the analysis of the diagnoses revealed that over 50% of these patients suffered from gastrointestinal disorders.
Thus the gastrointestinal tract is very likely to be a further source of increased diadenosine tetraphosphate hydrolase activities in various states of disease. Another candidate is the pancreas. All cases of pancreatitis showed elevated hydrolase activity.
We have recently shown that human platelets contain Ap 3 A and Ap 4 A degrading activities (3). However, since the activities measured in serum and in plasma were identical, it appeared that platelets did not contribute to the hydrolase activity found in serum.
Human erythrocytes contain a phosphodiesterase activity which is strongly inhibited by Zn 2+ (11) . On the basis of this property, the erythrocyte enzyme is not identical with the diadenosine tetraphosphate hydrolase from serum, since the serum enzyme is strongly stimulated by Zn 2+ (1) . Furthermore there were no differences in enzyme activities between slightly haemolytic and non-haemolytic sera from the same donor.
A possible source of the serum diadenosine tetraphosphate hydrolase, however, might be the endothelial lining of blood vessels. An ectoenzyme which cleaves Ap 3 A (which is also a Substrate of the serum hydrolase) has recently been demonstrated on endothelial cells of pig aorta (12) . We have confirmed and extended these results by detecting Ap 3 A and Ap 4 A degrading activities ön calf aortic endothelium (unpublished results). The glycoprotein structure of the serum hydrolase (1) suggests that this enzyme might originate from the membrane of vascular endothelial cells.
The variety of organs discussed here äs a source of increased enzyme activities in the serum stimulates the questioii of the existence of isoenzymes. In analogy with enzymes such äs alkaline phosphatase or lactate dehydrogenase, it is an obvious assumption that diadenosine tetraphosphate hydrolase also occürs in multiple molecular forms.
During the purification there were no indications for the existence of isoenzymes (1), but there are several possible reasons for this. Firstly, we isolated the enzyme from ACD-(acidum citricum/dextrose)-plasma. Since it is known that nucleotide pyrophosphatases are dependent on divalent cations for füll activity some of the possible isoenzymes may have been inactivated by the complexing agent citrate. Secondly, it is possible that the Separation techniques used were not sufficient to give a good resolution of isoenzymes. Thirdly, the enzyme was purified from plasma of healthy donors. Isozymes which are only formed under certain pathological conditions would have escaped our notice.
It should be mentioned that the highly purified enzyme (5000-fold) possessed a 5'-nucleotide phospho^· diesterase activity (1) . These enzymes are known to exist in different molecular forms in human serum (6, 7) . For example, four activities were found in sera of healthy persons and under certäin pathological conditions a fifth isozyme appeared. In a very recent paper even more activities were detected in the serum (8) . We assume that at least one of the S'-nucleotide phosphpdiesterases is identical with the diadenosine tetraphosphate hydrolase. Further research is necessary to find out whether all the phosphodiesterases can cleave Ap4A and whether there are diadenosine tetraphosphate hydrpläses withöut any phosphodiesterase activity.
